In the Virus-Like Particle Translational Oncology Laboratory, Qizhi Cathy Yao, M.D., Ph.D. is developing non-infectious HIV virus-like particles (VLPs) as candidate HIV mucosal vaccines for both ...

The formation of VLP is depicted in Figure 1. Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has ...

Here, the authors characterize a recombinant virus-like particle polio vaccine with stabilized capsid proteins and show comparable immunogenicity to the current inactivated polio vaccine.

Nipah virus (NiV), has shown itself to be an emerging zoonotic virus which may yet have severe human health implications. It has attracted attention due to its high fatality rates and growing ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

The development of vaccines against NiV is a priority, with various approaches under investigation, including virus-like particle-based and mRNA-based vaccines. However, no vaccine is yet approved ...

The virus particle comes apart ... viruses are then released from the cell and can go on to infect other cells. Like other viruses, the dengue virus is a microscopic structure that can only ...